IP Library Granted Patent US 9,259,492
Granted Patent B2
US 9,259,492 · App. 13/805,763 · Granted Feb 16, 2016

Tuned multifunctional magnetic nanoparticles for biomedicine

Inventors: Kannan M. Krishnan (Seattle, WA); R. Matthew Ferguson (Seattle, WA); Amit Praful Khandhar (Bothell, WA)
Assignee: University of Washington through its Center for Commercialization
A61K49/1824A61K9/14A61K41/0052A61K49/186A61K49/1854C12Q1/02Y10T428/2982Y10T428/2998
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,259,492
App. No.
13/805,763
Granted
Feb 16, 2016
Kind
B2
Abstract

Magnetic nanoparticles and related devices and methods are described. Compositions and methods can include magnetic nanoparticles having a narrow size distribution for use in diagnostics and therapeutics.

Claims (20)

1. A method of producing magnetic nanoparticles with a tuned size distribution for magnetic particle imaging, the method comprising:

selecting a diameter of a magnetic nanoparticle that produces a maximum spatial resolution or a maximum signal intensity at a frequency used in magnetic particle imaging;

producing a population of magnetic nanoparticles having a median diameter of approximately the selected diameter of the magnetic nanoparticle that produces the maximum spatial resolution or the maximum signal intensity, wherein the population of the magnetic nanoparticles has a narrow size distribution.

2. A method for imaging magnetic nanoparticles, the method comprising:

selecting a diameter of a magnetic nanoparticle that produces a maximum spatial resolution or a maximum signal intensity at a frequency used in magnetic particle imaging;

providing a population of magnetic nanoparticles having a median diameter of approximately the selected diameter of the magnetic nanoparticle that produces the maximum spatial resolution or the maximum signal intensity, wherein the population of the magnetic nanoparticles has a narrow size distribution;

administering the population of magnetic nanoparticles to a subject; and

exciting at least one magnetic nanoparticle in the population of magnetic nanoparticles with an imaging system.

3. The method of claim 2 , wherein the imaging system is configured to perform magnetic particle imaging (MPI).

4. The method of claim 2 , wherein the imaging system is configured to perform magnetic resonance imaging (MRI).

5. The method of claim 2 , wherein the imaging system is configured to perform MPI and MRI in combination.

6. The method of claim 2 , wherein greater than about 70% of the magnetic nanoparticles in the population have a magnetic core diameter that is less than 8.8 nm from the median number-weighted diameter.

7. The method of claim 2 , wherein the narrow size distribution comprises a log-normal distribution with median number-weighted magnetic core diameter and a geometric standard deviation of less than about 1.22.

8. The method of claim 2 , wherein greater than about 70% of the magnetic nanoparticles in the population have a magnetic core diameter that is less than 3 nm from the median number-weighted diameter.

9. The method of claim 2 , wherein the narrow size distribution comprises a log-normal distribution with median number-weighted magnetic core diameter and a geometric standard deviation of less than about 1.11.

10. The method of claim 2 , wherein the population of magnetic nanoparticles comprises a median magnetic core diameter ranging from about 12 nm to about 30 nm or from about 5 nm to about 30 nm.

11. The method of claim 2 , wherein the population of magnetic nanoparticles comprises a median hydrodynamic diameter ranging from about 30 nm to about 100 nm in aqueous solution.

12. The method of claim 2 , wherein at least one magnetic nanoparticle of the population of magnetic nanoparticles comprises an iron oxide core coated with a polymer.

13. The method of claim 12 , wherein the iron oxide core is a single crystal.

14. The method of claim 12 , wherein the polymer is selected from the group consisting of an ethylene oxide/propylene oxide block copolymer, polyethylene oxide polymer, polyethylene glycol polymer, poly (maleic anhydride alt-1-octadecene) polymer and poly (maleic anhydride alt-1-octadecene)-polyethylene glycol polymer (PMAO-PEG).

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 30, 2014
From: UNIVERSITY OF WASHINGTON / CENTER FOR COMMERCIALIZATION
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 033446/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2013
From: KRISHNAN, KANNAN M.; FERGUSON, R. MATTHEW; KHANDHAR, AMIT PRAFUL
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 029817/0054 →
Continuity (3)
Provisional Application 61356892 · Jun 21, 2010
Provisional Application 61441933 · Feb 11, 2011
Related Publication 20130149539A1 · Jun 13, 2013